Key result
Ingezim PPA COMPAC ELISA demonstrates ~99% diagnostic specificity in ASF-naïve US pigs.
Why the study?
What is the diagnostic specificity of the Ingezim PPA COMPAC ELISA for detecting African swine fever virus antibodies in the US pig population?
Observational (n=1,791)
What is the diagnostic specificity of the Ingezim PPA COMPAC ELISA for detecting African swine fever virus antibodies in the US pig population?
The Ingezim PPA COMPAC ELISA demonstrates high diagnostic specificity (99.4%) in the ASF naïve pig population of the United States, supporting its potential use for disease surveillance and proving freedom of disease.
Answers are grounded in this paper and cite their sources.
May aid post-outbreak ASF freedom-of-disease proof in U.S. swine; leaves open large-scale field validation before routine adoption.
African swine fever (ASF) is a highly contagious haemorrhagic disease of pigs that has the potential to cause mortality nearing 100% in naïve animals. While an outbreak of ASF in the United States' pig population (domestic and feral) has never been reported, an introduction of the disease has the potential to cause devastation to the pork industry and food security. During the recovery phase of an outbreak, an antibody detection diagnostic assay would be required to prove freedom of disease within the previously infected zone and eventually nationwide. Animals surviving an ASF infection would be considered carriers and could be identified through the persistence of ASF viral antibodies. These antibodies would demonstrate exposure to the disease and not vaccination, as there is no ASF vaccine available. A well-established commercial enzyme-linked immunosorbent assay (ELISA) detects antibodies against ASF virus (ASFV), but the diagnostic specificity of the assay had not been determined using serum samples from the pig population of the United States. This study describes an evaluation of the World Organization for Animal Health (OIE)-recommended Ingezim PPA COMPAC ELISA using a comprehensive cohort (n = 1791) of samples collected in the United States. The diagnostic specificity of the assay was determined to be 99.4% (95% confidence interval (CI): [98.9, 99.7]). The result of this study fills a gap in understanding the performance of the Ingezim PPA COMPAC ELISA in the ASF naïve pig population of the United States.
No takes yet. Share an insight, caveat, or question.
Bergeron et al. (2017) conducted an observational in African swine fever (n=1,791). Ingezim PPA COMPAC ELISA was evaluated on Diagnostic specificity (95% CI 98.9-99.7). The Ingezim PPA COMPAC ELISA demonstrated a diagnostic specificity of 99.4% in a cohort of 1,791 serum samples from the ASF-naïve pig population of the United States.
Synapse has enriched 10 related papers. Consider them for comparative context: